Randomized Phase II trial study of lenalidomide, bortezomib and dexamethsone (RVD)with or without Panobinostat in new MM pts
Clinical Trial Grant
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
September 1, 2016
End Date
October 24, 2017
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
September 1, 2016
End Date
October 24, 2017